"New York Oncology Hematology (NYOH) is the leading provider of community-based cancer care and blood disorder services. With six convenient locations in Albany, Amsterdam, Clifton Park in Saratoga County, Hudson, and Troy, our team of 35 physicians and more than 350 cancer care specialists see more than 100,000 cancer visits a year."

During the past decade, Albany Regional Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Albany Regional Cancer Center" #1 sponsor was "Abbott" with 3 trials, followed by "Dendreon" with 3 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored, "Agennix" with 1 trials sponsored and "Alliance for Clinical Trials in Oncology" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albany Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Cell Pathways" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "OSI Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Albany Regional Cancer Center" are "Prostate Cancer" (4 trials), "Breast Cancer" (2 trials), "Carcinoma, Renal Cell" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Albany Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Albany Regional Cancer Center" are "Drug" (10 trials), "Biological" (3 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "ABT-510 - Thrombospondin-1 Mimetic" (1 trials), "ABT-510/Thrombospondin-1 mimetic" (1 trials), "ABT-751" (1 trials) and "APC-Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Albany Regional Cancer Center" are 7 trials for "All" genders, 5 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Albany Regional Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Albany Regional Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Albany Regional Cancer Center, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".